Showing results (521-530 of 530) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 530 results.
JAMA|May 4, 2021
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical TrialSiri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
The Lancet. Rheumatology|April 7, 2024
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trialKaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
The New England Journal of Medicine|November 13, 2018
Low-Dose Methotrexate for the Prevention of Atherosclerotic EventsPaul M Ridker, Brendan M Everett, Aruna Pradhan, et al.
Contemporary Clinical Trials|July 17, 2012
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United StatesKenneth G Saag, Penny E Mohr, Laura Esmail, et al.
Annals of Internal Medicine|February 18, 2020
Adverse Effects of Low-Dose Methotrexate: A Randomized TrialDaniel H Solomon, Robert J Glynn, Elizabeth W Karlson, et al.
Biomed Research International|April 3, 2015
TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapyHelena Canhão, Ana Maria Rodrigues, Maria José Santos, et al.
Contemporary Clinical Trials Communications|July 26, 2016
A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention materialMaria I Danila, Ryan C Outman, Elizabeth J Rahn, et al.
The New England Journal of Medicine|March 20, 2013
Surgery versus physical therapy for a meniscal tear and osteoarthritisJeffrey N Katz, Robert H Brophy, Christine E Chaisson, et al.
Arthritis Care & Research|May 26, 2018
Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in GoutDavid Bursill, William J Taylor, Robert Terkeltaub, et al.
Nature Genetics|October 15, 2024
A genome-wide association analysis reveals new pathogenic pathways in goutTanya J Major, Riku Takei, Hirotaka Matsuo, et al.
Pageof 53